Abstract
Donor leukocyte infusion (DLI) was carried out on a 12-year-old girl with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who received allogeneic bone marrow transplantation from an HLA-identical sibling. This is the first report of DLI use before the onset of hematological relapse monitored by the results of RT-PCR. This patient has been in CR for 11 months after BMT, suggesting this alternative treatment is promising for Ph+ ALL with positive reverse transcriptase-polymerase chain reaction (RT-PCR) following BMT.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yazaki, M., Andoh, M., Ito, T. et al. Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion. Bone Marrow Transplant 19, 393–394 (1997). https://doi.org/10.1038/sj.bmt.1700663
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700663
- Springer Nature Limited
Keywords
This article is cited by
-
Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Current Hematologic Malignancy Reports (2013)
-
Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant
Bone Marrow Transplantation (2008)
-
B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL
Bone Marrow Transplantation (2008)
-
Twenty Years’ Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome—Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
International Journal of Hematology (2004)
-
Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia
Leukemia (2003)